Professor Dr. Stoecker writes:
"...The Lübeck vaccine uses a tailored, small and trivial genetically engineered antigen that the body does not need to synthesise itself as is the case with nucleic acid-based methods. In the organism of the recipient, it induces the production of antibodies against the Spike protein of SARS-Cov2 that the virus uses to bind to the angiotensin-2 receptors on endothelial cells, alveolar cells and enterocytes in unvaccinated individuals. By this blocking, the antibodies prevent infection of the cells and the virus is unable to bind..."
Professor Dr. Stoecker writes: "...The Lübeck vaccine uses a tailored, small and trivial genetically engineered antigen that the body does not need to synthesise itself as is the case with nucleic acid-based methods. In the organism of the recipient, it induces the production of antibodies against the Spike protein of SARS-Cov2 that the virus uses to bind to the angiotensin-2 receptors on endothelial cells, alveolar cells and enterocytes in unvaccinated individuals. By this blocking, the antibodies prevent infection of the cells and the virus is unable to bind..."